Bionovate Technologies Corp. announced earnings results for the third quarter ended March 31, 2020. For the third quarter, the company announced operating loss was USD 2,748 compared to USD 5,392 a year ago. Net loss was USD 24,138 compared to USD 25,334 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.16 a year ago. For the nine months, operating loss was USD 27,110 compared to USD 38,830 a year ago. Net loss was USD 99,083 compared to USD 160,172 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 1.03 a year ago.